Demographic Pattern and Mortality Risk Factors for Prescription Opioid Overdose Hospitalizations: Results From Nationwide Inpatient Sample Analysis.
mortality
opioid use disorders
overdose prevention
prescription opioid
risk factors
substance recreational use
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
accepted:
15
06
2021
entrez:
19
7
2021
pubmed:
20
7
2021
medline:
20
7
2021
Statut:
epublish
Résumé
Objectives To explore the demographic patterns of hospitalizations related to prescription opioid overdose (POD) and evaluate the mortality risk of association in POD inpatients. Methodology We conducted a cross-sectional study using the Nationwide Inpatient Sample of 184,711 POD inpatients. A binomial logistic regression model was used to evaluate the odds ratio (OR) of association for mortality risk due to comorbidities (substance use disorders (SUD) and medical complications) in POD inpatients. Results POD inpatients were majorly females (54.1%), older adults aged 51-75 years (48.5%), whites (81.5%), and from lower household income quartet (32.8%). The most prevalent comorbid SUD among POD inpatients was alcohol (15.7%), followed by cannabis (5.7%), cocaine (4.2%), and amphetamine (1.8%). Comorbid alcohol use disorders had a minimally increased association with mortality but were not statistically significant (OR = 1.036; P = 0.438). POD in patients with cardiac arrest had the highest risk of mortality (OR = 103.423; P < 0.001), followed by shock (OR = 15.367; P < 0.001), coma (OR = 13.427; P < 0.001), and respiratory failure (OR = 12.051; P < 0.001). Conclusions Our study indicates that the hospitalizations related to POD were more prevalent among females, elders between 51 and 75 years of age, whites, and those in the lower household income quartet. The prevalence of prescription opioid use and the hospitalization related to POD remains a significant public health issue. POD inpatients with medical complications were at a higher risk of mortality than with comorbid SUD.
Identifiants
pubmed: 34277265
doi: 10.7759/cureus.15674
pmc: PMC8281797
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e15674Informations de copyright
Copyright © 2021, Sejdiu et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Behav Sci (Basel). 2019 Jul 13;9(7):
pubmed: 31337011
Am Fam Physician. 2019 Oct 1;100(7):416-425
pubmed: 31573166
Am J Addict. 2019 Feb;28(2):111-118
pubmed: 30701620
Arthritis Rheumatol. 2016 Feb;68(2):323-31
pubmed: 26473742
Pediatrics. 2017 Mar;139(3):
pubmed: 28219963
J Addict Med. 2017 Jul/Aug;11(4):315-319
pubmed: 28426439
Exp Clin Psychopharmacol. 2008 Oct;16(5):405-16
pubmed: 18837637
Am J Prev Med. 2020 Feb;58(2):250-253
pubmed: 31959322
Cureus. 2020 Oct 20;12(10):e11058
pubmed: 33224654
Pain Med. 2012 Sep;13(9):1181-211
pubmed: 22905834
MMWR Surveill Summ. 2020 Jan 31;69(1):1-14
pubmed: 31999681
Addiction. 2020 Mar;115(3):493-504
pubmed: 31691390
PLoS One. 2020 Jan 17;15(1):e0227966
pubmed: 31951640
Physiol Rev. 2009 Oct;89(4):1379-412
pubmed: 19789384
JAMA. 2011 Apr 6;305(13):1315-21
pubmed: 21467284
Anesth Analg. 2017 Nov;125(5):1741-1748
pubmed: 29049118
J Psychosom Res. 1990;34(5):525-34
pubmed: 2231486
JAMA Pediatr. 2020 Feb 1;174(2):141-148
pubmed: 31841589
Demography. 2017 Jun;54(3):1175-1202
pubmed: 28324483
Addict Health. 2019 Oct;11(4):223-233
pubmed: 32206215